D89.89, Other specified disorders involving the immune mechanism, not elsewhere classifiedICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L34200, Removal of Benign Skin Lesions
J15
CGS-J15-L39038, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15
CGS-J15-L34037, Flow Cytometry
J15
CGS-J18-L34037, Flow Cytometry
J18
CGS-J18-L39038, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J18
CGS-J18-L34200, Removal of Benign Skin Lesions
J18
WPS-J5-L39044, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J5
A58761, Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J5
NGS-J6-L39297, Off-label Use of Rituximab and Rituximab Biosimilars
J6
A58963, Billing and Coding: Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)
J6
NGS-J6-L39226, Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)
J6
NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6
A59101, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J6
WPS-J8-L39044, MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J8
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
FIRST_COAST-L38227, Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
J9
FIRST_COAST-L38918, Respiratory Pathogen Panel Testing
J9
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
NOVITAS-JH-L38229, Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
JH
NOVITAS-JH-L38916, Respiratory Pathogen Panel Testing
JH
Ask Backwork about documentation requirements, denial risks, or coverage in your state.